We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

73 hedge funds and large institutions have $21.1M invested in T2 Biosystems, Inc in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $470K | Put options by funds: $379K

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

6% less funds holding

Funds holding: 78 → 73 (-5)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

39% less capital invested

Capital invested by funds: $34.6M → $21.1M (-$13.5M)

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
14
Closed
12
Calls
$470K
Puts
$379K
Net Calls
+$91K
Net Calls Change
-$22K

Top Buyers

Rank Fund Capital Flow
1
N
Natixis
France
+$539K
2
GCP
GSA Capital Partners
United Kingdom
+$166K
3
WF
Welch & Forbes
Massachusetts
+$136K
4
Franklin Resources
Franklin Resources
California
+$111K
5
JP Morgan Chase
JP Morgan Chase
New York
+$55.4K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.66M
2
Millennium Management
Millennium Management
New York
-$2.06M
3
GS
Gagnon Securities
New York
-$357K
4
BCM
Bridgeway Capital Management
Texas
-$302K
5
Osaic Holdings
Osaic Holdings
Arizona
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
AMC
51
Asset Management Corp
Illinois
$16K – – –
IWC
52
Integrated Wealth Concepts
Massachusetts
$16K – – –
FWM
53
Focused Wealth Management
New York
$15K – – –
HR
54
Howe & Rusling
New York
$14K – – –
WP
55
WealthPLAN Partners
Nebraska
$14K – – –
CL
56
CIM LLC
New York
$13K – – –
WAP
57
Wealthcare Advisory Partners
Pennsylvania
$13K – – –
Bank of America
58
Bank of America
North Carolina
$10K – – –
EWM
59
Empirical Wealth Management
Washington
$10K – – –
IA
60
Inspire Advisors
Idaho
$10K – – –
NWA
61
Navis Wealth Advisors
New York
$9K – – –
RWP
62
Ridgecrest Wealth Partners
California
$9K – – –
Koshinski Asset Management
63
Koshinski Asset Management
Illinois
$8.83K +$10.1K +2 New
Credit Agricole
64
Credit Agricole
France
$6K – – –
DAC
65
Dividend Assets Capital
South Carolina
$5K – – –
IA
66
IFP Advisors
Florida
$5K – – –
Group One Trading
67
Group One Trading
Illinois
$5K +$5.03K +1 New
UBS Group
68
UBS Group
Switzerland
$3K -$10.1K -2 -67%
BG
69
Bollard Group
Massachusetts
$3K – – –
COCM
70
Charter Oak Capital Management
New Hampshire
$3K – – –
Simplex Trading
71
Simplex Trading
Illinois
$3K – – –
Wells Fargo
72
Wells Fargo
California
$3K – – –
TRCT
73
Tower Research Capital (TRC)
New York
$2K -$5.03K -1 Closed
CG
74
Cutler Group
California
$2K – – –
WT
75
Washington Trust
Rhode Island
$2K – – –
1 2
3
4

TTOO Hedge Fund Activity: Q3 2021 in Review

73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2021, worth a combined $21.1M — down 39% from $34.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Natixis, opening a new position worth an estimated $539K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.66M sold.

  • 73 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2021, down from 78 in Q2 2021.
  • Funds reported $21.1M of T2 Biosystems, Inc stock for Q3 2021, down 39% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2021 was Natixis, an estimated $539K added.
  • The largest T2 Biosystems, Inc seller in Q3 2021 was Renaissance Technologies, an estimated $2.66M sold.

Based on aggregated 13F filings for Q3 2021.